245 related articles for article (PubMed ID: 31103898)
1. Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities.
Fei BL; Tu S; Wei Z; Wang P; Qiao C; Chen ZF
Eur J Med Chem; 2019 Aug; 176():175-186. PubMed ID: 31103898
[TBL] [Abstract][Full Text] [Related]
2. Copper(II) and iron(III) complexes of chiral dehydroabietic acid derived from natural rosin: metal effect on structure and cytotoxicity.
Fei BL; Hui CN; Wei Z; Kong LY; Long JY; Qiao C; Chen ZF
Metallomics; 2021 Apr; 13(4):. PubMed ID: 33765148
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of optically pure chiral binuclear copper(ii) complexes based on a rosin derivative as highly potential anticancer agents.
Fei BL; Tu S; Wei Z; Wang P; Long JY; Qiao C; Chen ZF
Dalton Trans; 2019 Oct; 48(41):15646-15656. PubMed ID: 31465061
[TBL] [Abstract][Full Text] [Related]
4. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Khan S; Zafar A; Naseem I
Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
[TBL] [Abstract][Full Text] [Related]
5. Enantiopure copper(II) complex of natural product rosin derivative: DNA binding, DNA cleavage and cytotoxicity.
Fei BL; Yin B; Li DD; Xu WS; Lu Y
J Biol Inorg Chem; 2016 Dec; 21(8):987-996. PubMed ID: 27628182
[TBL] [Abstract][Full Text] [Related]
6. Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells.
Shi X; Chen Z; Wang Y; Guo Z; Wang X
Dalton Trans; 2018 Apr; 47(14):5049-5054. PubMed ID: 29561011
[TBL] [Abstract][Full Text] [Related]
7. Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer.
Jiang M; Yan Q; Fu Y; Meng L; Gai S; Pan X; Qin Y; Jiang C
J Inorg Biochem; 2024 Jul; 256():112550. PubMed ID: 38599004
[TBL] [Abstract][Full Text] [Related]
8. Anticancer potency of copper(II) complexes of thiosemicarbazones.
Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction.
Wang H; Wei J; Jiang H; Zhang Y; Jiang C; Ma X
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800091
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.
Nagababu P; Barui AK; Thulasiram B; Devi CS; Satyanarayana S; Patra CR; Sreedhar B
J Med Chem; 2015 Jul; 58(13):5226-41. PubMed ID: 26068145
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
13. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.
Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J
ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and multiple targeting with selectivity: Anticancer property of ternary metal phenanthroline-maltol complexes.
Ng CH; Tan TH; Tioh NH; Seng HL; Ahmad M; Ng SW; Gan WK; Low ML; Lai JW; Zulkefeli M
J Inorg Biochem; 2021 Jul; 220():111453. PubMed ID: 33895694
[TBL] [Abstract][Full Text] [Related]
15. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK
Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073
[TBL] [Abstract][Full Text] [Related]
16. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
[TBL] [Abstract][Full Text] [Related]
17. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
Zafar A; Singh S; Naseem I
J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors.
Fernandes C; Horn A; Lopes BF; Bull ES; Azeredo NFB; Kanashiro MM; Borges FV; Bortoluzzi AJ; Szpoganicz B; Pires AB; Franco RWA; Almeida JCA; Maciel LLF; Resende JALC; Schenk G
J Inorg Biochem; 2015 Dec; 153():68-87. PubMed ID: 26485179
[TBL] [Abstract][Full Text] [Related]
19. Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer.
Gou Y; Chen M; Li S; Deng J; Li J; Fang G; Yang F; Huang G
J Med Chem; 2021 May; 64(9):5485-5499. PubMed ID: 33861929
[TBL] [Abstract][Full Text] [Related]
20. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
